| Code | 6812B | ||||||||||
| MA number | 27/0485/15-S | ||||||||||
| Product Form: | tbl plg 84x2 mg (fľ.HDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Neuraxpharm Bohemia s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 27 - ANTIPARKINSONICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 30.11.2015 |
| Pediatric posology: | Yes |
| PIL: |
PIL_Ropinirol Neuraxpharm_2 mg_4 mg_8 mg_06.2024.pdf
|
| SPC: |
SPC_Ropinirol Neuraxpharm_2 mg_4 mg_8 mg_06.2024.pdf
|
| Safety feature | Yes |
| Data update: | 20.12.2023 |
